Study programme
Classes
- Dermatovenereology +2E0207370 | Faculty of Medicine in Pilsen
- DermatovenerologyEA0907370 | Faculty of Medicine in Pilsen
- Modern Trends in Aesthetic DermatologyEAV370X02 | Faculty of Medicine in Pilsen
- Dermatology and Internal MedicineEAV370X03 | Faculty of Medicine in Pilsen
- Phototherapy in dermatovenereology - methods and mechanismED0003203 | Faculty of Medicine in Pilsen
- ? +7ED1P458 | Faculty of Medicine in Pilsen
- Psoriasis and Comorbities, their Prevalence and Impact on the TreatmentEDDP1051 | Faculty of Medicine in Pilsen
Publications
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Atopic Dermatitis: Current Recommendations for Diagnosis and Treatment. Part I2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
- Atopic Dermatitis: Current Guidelines for Diagnosis and Treatment. Part II2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Keratinization disorders2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Psoriasis treatment goals - time for a change?2023 | Faculty of Medicine in Pilsen
- Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
- Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
- Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
Loading network view...
